Implementing Patient Education and Supportive Care in EGFR Mutated Metastatic Non-Small Cell Lung Cancer

In this segment, the panel discusses how complex treatment education is operationalized in routine practice for patients with EGFR mutated metastatic non-small cell lung cancer. Building on the prior discussion of prophylactic strategies and supportive care, Dr. Devarakonda asks how clinicians realistically deliver and reinforce these teachings within busy oncology clinics.

Dr. Singhi describes a structured, team based approach, emphasizing repeated education and multidisciplinary reinforcement to ensure patients understand both treatment expectations and supportive care measures. Dr. Rotow and Dr. Rous highlight the importance of dedicated chemotherapy teaching visits, written educational materials, pharmacist involvement, and close early follow up. The panel acknowledges that the initial discussion can feel overwhelming for patients, particularly in the context of a new cancer diagnosis. However, they emphasize that repetition, proactive communication, and coordinated team support are critical to improving adherence, minimizing toxicity, and sustaining long term treatment success in EGFR mutated metastatic non-small cell lung cancer.